OpenAI is worth $500 billion now. What are its investors getting back? This is an edition of The Atlantic Daily, a newsletter ...

A Swedish-led study validated a self-administered digital cognitive test (BioCog) in primary care, showing it can accurately ...

Running Pi-hole alongside services like Nextcloud or Jellyfin sounds easy to manage, easy to back up, and perfectly functional—at least on paper. That setup worked fine for a while, but over time, it ...

Down in Temple Bar Gallery + Studios, filmmaker and artist Frank Sweeney is set to launch his new film, Go Ye Afar this evening.

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Recursion Pharmaceuticals, Inc. is one of them. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a ...

Recursion Pharmaceuticals (NASDAQ: RXRX), a biotech focused on artificial intelligence (AI), became a publicly traded company in 2021 -- a time when AI did not grab nearly as much attention (if any at ...

Who doesn’t love a good routine? Whether it’s for the morning, night, or somewhere in between, routines can keep us on track and on schedule while also helping us feel like we’re accomplishing ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

If you’re preparing for the EC-Council’s CEH exam or exploring other security certifications such as Security+, CySA+, CISSP, ...